Cite

HARVARD Citation

    Antonia, S. et al. (2019). Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. Lancet oncology. 20 (10), pp. 1395-1408. [Online]. 
  
Back to record